Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients

BACKGROUND: The clinical course of cutaneous melanoma (CM) can differ significantly for patients with identical stages of disease, defined clinico-pathologically, and no molecular markers differentiate patients with such a diverse prognosis. This study aimed to define the prognostic value of whole g...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sigalotti, Luca, Covre, Alessia, Fratta, Elisabetta, Parisi, Giulia, Sonego, Paolo, Colizzi, Francesca, Coral, Sandra, Massarut, Samuele, Kirkwood, John M, Maio, Michele
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3539917/
https://ncbi.nlm.nih.gov/pubmed/22950745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-10-185
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares